TY - JOUR
T1 - Consensus recommendations on the use of 18F-FDG PET/CT in lung disease
AU - Chen, Delphine L.
AU - Ballout, Safia
AU - Chen, Laigao
AU - Cheriyan, Joseph
AU - Choudhury, Gourab
AU - Denis-Bacelar, Ana M.
AU - Emond, Elise
AU - Erlandsson, Kjell
AU - Fisk, Marie
AU - Fraioli, Francesco
AU - Groves, Ashley M.
AU - Gunn, Roger N.
AU - Hatazawa, Jun
AU - Holman, Beverley F.
AU - Hutton, Brian F.
AU - Iida, Hidehiro
AU - Lee, Sarah
AU - MacNee, William
AU - Matsunaga, Keiko
AU - Mohan, Divya
AU - Parr, David
AU - Rashidnasab, Alaleh
AU - Rizzo, Gaia
AU - Subramanian, Deepak
AU - Tal-Singer, Ruth
AU - Thielemans, Kris
AU - Tregay, Nicola
AU - van Beek, Edwin J.R.
AU - Vass, Laurence
AU - Vidal Melo, Marcos F.
AU - Wellen, Jeremy W.
AU - Wilkinson, Ian
AU - Wilson, Frederick J.
AU - Winkler, Tilo
N1 - Publisher Copyright:
COPYRIGHT © 2020 by the Society of Nuclear Medicine and Molecular Imaging.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases that interfere with gas exchange through alterations of the pulmonary parenchyma, airways, or vasculature. To date, however, there are no widely accepted standard acquisition protocols or imaging data analysis methods for pulmonary 18F-FDG PET/CT in these diseases, resulting in disparate approaches. Hence, comparison of data across the literature is challenging. To help harmonize the acquisition and analysis and promote reproducibility, we collated details of acquisition protocols and analysis methods from 7 PET centers. From this information and our discussions, we reached the consensus recommendations given here on patient preparation, choice of dynamic versus static imaging, image reconstruction, and image analysis reporting.
AB - PET with 18F-FDG has been increasingly applied, predominantly in the research setting, to study drug effects and pulmonary biology and to monitor disease progression and treatment outcomes in lung diseases that interfere with gas exchange through alterations of the pulmonary parenchyma, airways, or vasculature. To date, however, there are no widely accepted standard acquisition protocols or imaging data analysis methods for pulmonary 18F-FDG PET/CT in these diseases, resulting in disparate approaches. Hence, comparison of data across the literature is challenging. To help harmonize the acquisition and analysis and promote reproducibility, we collated details of acquisition protocols and analysis methods from 7 PET centers. From this information and our discussions, we reached the consensus recommendations given here on patient preparation, choice of dynamic versus static imaging, image reconstruction, and image analysis reporting.
KW - FDG
KW - Lung disease
KW - PET/CT
KW - Pulmonary imaging
UR - http://www.scopus.com/inward/record.url?scp=85097113549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097113549&partnerID=8YFLogxK
U2 - 10.2967/jnumed.120.244780
DO - 10.2967/jnumed.120.244780
M3 - Article
C2 - 32948678
AN - SCOPUS:85097113549
SN - 0161-5505
VL - 61
SP - 1701
EP - 1707
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 12
ER -